Senior insider sale
CEO at ROIVANT SCIENCES LTD. — senior position signals high conviction
$18.31M
648.28K shares
What this filing means
GLINE MATTHEW plans to sell 648.28K shares of ROIVANT SCIENCES LTD. valued at approximately $18.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/16/2026ACC: 0001965301-26-000040
DirectorOfficer· CEO
Since Oct 2021
648.28K
Shares to sell
$18.31M
Approx. market value
289.77K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
RSU Grant - Grant date 07/26/2024
n/a
3/31/2026
246.28KCVAR Grant - Grant Date 03/26/2020
n/a
3/30/2026
43.49KTotal acquired289.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | RSU Grant - Grant date 07/26/2024 n/a | 246.28K | — |
3/30/2026 | CVAR Grant - Grant Date 03/26/2020 n/a | 43.49K | — |
| Total | 289.77K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
304.68K
Market value
$8.44M
3/30/2026
—Completed
Units to sell
53.83K
Market value
$1.42M
3/30/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
289.77K
Market value
$8.45M
4/16/2026
Total
Units
648.28K
Value
$18.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/30/2026 | 304.68K | $8.44M | — | Completed |
3/30/2026 | 53.83K | $1.42M | — | Completed |
| Planned — Approximate Date | ||||
4/16/2026 | 289.77K | $8.45M | NASDAQ | Planned |
| Total | 648.28K | $18.31M | ||